drugset / Trial / NCT03474770
BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine safety signals and demonstrate seizure reduction in adults with FIAS treated with BIS-001ER as an add-on therapy in an in-patient and out-patient study design.
Timeline
- Start
- 2018-04-10
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 1.75 mg | — |